ORIC Pharmaceuticals, Inc.
DE ˙ DB ˙ US68622P1093
6,51 € ↑0,13 (2,10%)
2026-06-04
DELAT PRIS
SecurityDE:4TZ / ORIC Pharmaceuticals, Inc.
InstitutionVanguard Group Inc
Latest Disclosed Ownership4,541,974 shares
Latest Disclosed Value $ 37,153,347
Vanguard Group Inc reports 2.33% decrease in ownership of 4TZ / ORIC Pharmaceuticals, Inc.

On January 29, 2026 - Vanguard Group Inc filed a 13F-HR form disclosing ownership of 4,541,974 shares of ORIC Pharmaceuticals, Inc. (DE:4TZ) valued at $31,339,621 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 7, 2025 disclosing 4,650,138 shares of ORIC Pharmaceuticals, Inc.. This represents a change in shares of -2.33% during the quarter. The current value of the position is $29,577,335 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-01-29 2025-12-31 13F ORIC PHARMACEUTICALS COM 68622P109 4,541,974 -108,164 -2.33 37,153 -33.42 0.0005
2025-11-07 2025-09-30 13F ORIC PHARMACEUTICALS COM 68622P109 4,650,138 1,525,445 48.82 55,802 75.95 0.0008
2025-08-11 2025-06-30 13F ORIC PHARMACEUTICALS COM 68622P109 3,124,693 -91,194 -2.84 31,716 76.74 0.0005
2025-05-09 2025-03-31 13F ORIC PHARMACEUTICALS COM 68622P109 3,215,887 12,098 0.38 17,945 -30.59 0.0003
2025-02-11 2024-12-31 13F ORIC PHARMACEUTICALS COM 68622P109 3,203,789 36,478 1.15 25,855 -20.36 0.0005
2024-11-13 2024-09-30 13F ORIC PHARMACEUTICALS COM 68622P109 3,167,311 -32,415 -1.01 32,465 43.51 0.0006
2024-08-13 2024-06-30 13F ORIC PHARMACEUTICALS COM 68622P109 3,199,726 317,671 11.02 22,622 -42.91 0.0004
2024-05-10 2024-03-31 13F ORIC PHARMACEUTICALS COM 68622P109 2,882,055 629,536 27.95 39,628 91.23 0.0008
2024-03-11 2023-12-31 13F/A-1 ORIC PHARMACEUTICALS COM 68622P109 2,252,519 -336,350 -12.99 20,723 32.31 0.0005
2024-02-14 2023-12-31 13F ORIC PHARMACEUTICALS COM 68622P109 2,252,519 -336,350 20,723 0.0004
2023-12-18 2023-09-30 13F/A-1 ORIC PHARMACEUTICALS COM 68622P109 2,588,869 791,843 44.06 15,663 12.32 0.0004
2023-11-14 2023-09-30 13F ORIC PHARMACEUTICALS COM 68622P109 2,588,869 791,843 15,663 0.0001
2023-08-14 2023-06-30 13F ORIC PHARMACEUTICALS COM 68622P109 1,797,026 153,952 9.37 13,945 48.89 0.0003
2023-07-14 2023-03-31 13F/A-1 ORIC PHARMACEUTICALS COM 68622P109 1,643,074 96,789 6.26 9,366 2.83 0.0002
2023-05-15 2023-03-31 13F ORIC PHARMACEUTICALS COM 68622P109 1,643,074 96,789 9,366 0.0000
2023-02-10 2022-12-31 13F ORIC PHARMACEUTICALS COM 68622P109 1,546,285 199,423 14.81 9,108 111.30 0.0002
2022-11-14 2022-09-30 13F ORIC PHARMACEUTICALS COM 68622P109 1,346,862 -66,869 -4.73 4,310 -31.94 0.0001
2022-08-12 2022-06-30 13F ORIC PHARMACEUTICALS COM 68622P109 1,413,731 -230,288 -14.01 6,333 -27.86 0.0002
2022-05-13 2022-03-31 13F ORIC PHARMACEUTICALS COM 68622P109 1,644,019 13,981 0.86 8,779 -63.36 0.0002
2022-02-14 2021-12-31 13F ORIC PHARMACEUTICALS COM 68622P109 1,630,038 31,116 1.95 23,960 -28.33 0.0005
2021-11-12 2021-09-30 13F ORIC PHARMACEUTICALS COM 68622P109 1,598,922 365,052 29.59 33,433 53.17 0.0008
2021-08-13 2021-06-30 13F ORIC PHARMACEUTICALS COM 68622P109 1,233,870 -21,337 -1.70 21,828 -29.02 0.0005
2021-05-14 2021-03-31 13F ORIC PHARMACEUTICALS COM 68622P109 1,255,207 387,656 44.68 30,752 4.72 0.0008
2021-02-12 2020-12-31 13F ORIC PHARMACEUTICALS COM 68622P109 867,551 441,385 103.57 29,366 175.50 0.0009
2020-11-16 2020-09-30 13F ORIC PHARMACEUTICALS COM 68622P109 426,166 -2,548 -0.59 10,659 -26.29 0.0004
2020-08-14 2020-06-30 13F ORIC PHARMACEUTICALS COM 68622P109 428,714 428,714 14,460 0.0005
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.